Literature DB >> 2250603

Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics.

L T Baxter1, R K Jain.   

Abstract

We have recently developed a general theoretical framework for transvascular exchange and extravascular transport of fluid and macromolecules in tumors. The model was applied to a homogeneous, alymphatic tumor with no extravascular binding. For this simplified system, the interstitial pressure was found to be a major contributing factor to the heterogeneous distribution of macromolecules within solid tumors. A steep pressure gradient was predicted at the periphery of the tumor. Our recent experiments have verified these predicted profiles. The purpose of this investigation was to apply this theoretical framework to the more realistic case of a nonuniformly perfused tumor. The role of lymphatics for macromolecular transport was also studied using the model. The uptake and distribution of IgG and its fragment, Fab, were simulated. The novel result from this work is that necrosis does not reduce the central interstitial pressure in a tumor. Other results showed that (i) macromolecules do not penetrate a necrotic core at early times after injection; (ii) at longer time periods after a bolus injection (days for Fab, months for IgG in a tumor of radius approximately 1cm) a "reservoir" of material may be formed in the necrotic core; (iii) continuous infusion or repeated injections should maintain a higher interstitial concentration of macromolecules; and (iv) lymphatics, if present in a tumor, would rapidly remove material and result in much lower concentration levels. The model is also used to explain some previous experimental data in the literature on antibody distribution.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2250603     DOI: 10.1016/0026-2862(90)90023-k

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  81 in total

1.  Simulation of the delivery of doxorubicin to hepatoma.

Authors:  Y M Goh; H L Kong; C H Wang
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

2.  Sensitivity analysis of an image-based solid tumor computational model with heterogeneous vasculature and porosity.

Authors:  Gregory L Pishko; Garrett W Astary; Thomas H Mareci; Malisa Sarntinoranont
Journal:  Ann Biomed Eng       Date:  2011-07-13       Impact factor: 3.934

3.  Mathematical Modelling of Convection Enhanced Delivery of Carmustine and Paclitaxel for Brain Tumour Therapy.

Authors:  Wenbo Zhan; Davis Yohanes Arifin; Timothy Ky Lee; Chi-Hwa Wang
Journal:  Pharm Res       Date:  2017-02-02       Impact factor: 4.200

4.  The effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systems.

Authors:  Min Wu; Hermann B Frieboes; Mark A J Chaplain; Steven R McDougall; Vittorio Cristini; John S Lowengrub
Journal:  J Theor Biol       Date:  2014-04-19       Impact factor: 2.691

Review 5.  Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products.

Authors:  Jessie L-S Au; Ze Lu; Roberto A Abbiati; M Guillaume Wientjes
Journal:  AAPS J       Date:  2019-02-01       Impact factor: 4.009

6.  Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Model Development.

Authors:  Fudan Zheng; Peng Hou; Clairissa D Corpstein; Lei Xing; Tonglei Li
Journal:  Pharm Res       Date:  2021-04-02       Impact factor: 4.200

7.  Multistage nanoparticles for improved delivery into tumor tissue.

Authors:  Triantafyllos Stylianopoulos; Cliff Wong; Moungi G Bawendi; Rakesh K Jain; Dai Fukumura
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

8.  Peptide-based PET quantifies target engagement of PD-L1 therapeutics.

Authors:  Dhiraj Kumar; Ala Lisok; Elyes Dahmane; Matthew McCoy; Sagar Shelake; Samit Chatterjee; Viola Allaj; Polina Sysa-Shah; Bryan Wharram; Wojciech G Lesniak; Ellen Tully; Edward Gabrielson; Elizabeth M Jaffee; John T Poirier; Charles M Rudin; Jogarao Vs Gobburu; Martin G Pomper; Sridhar Nimmagadda
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

Review 9.  1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors.

Authors:  R K Jain
Journal:  Ann Biomed Eng       Date:  1996 Jul-Aug       Impact factor: 3.934

10.  A tumor cord model for doxorubicin delivery and dose optimization in solid tumors.

Authors:  Steffen Eikenberry
Journal:  Theor Biol Med Model       Date:  2009-08-09       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.